Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomas
Approximately a half of patients with large uveal melanoma develop LB around 2.5 years after brachytherapy. Further optimization of treatment strategies, including both therapeutic and preventive measures, has the potential to enhance the functional outcome after episcleral plaque therapy for large UMs.
Authors
- Bernard Schmidt
- W. Sauerwein (ORCID: https://orcid.org/0000-0002-5027-5913)
- Eva Biewald (ORCID: https://orcid.org/0000-0002-5941-1686)
- Maja Guberina (ORCID: https://orcid.org/0000-0003-3218-0539)
- Nika Guberina
- Leyla Jabbarli (ORCID: https://orcid.org/0000-0001-7370-5077)
- Martin Stuschke (ORCID: https://orcid.org/0000-0001-6836-0940)
- Dirk Flühs
- Nikolaos Emmanouel Bechrakis (ORCID: https://orcid.org/0000-0002-0180-1112)
- Philipp Rating (ORCID: https://orcid.org/0000-0003-3621-9007)
- Miltiadis Fiorentzis
- Norbert Bornfeld
Institutions
- Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE)
- National Center for Tumor Diseases (DE)
- Essen University Hospital (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- University of Duisburg-Essen (DE)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1186/s13014-024-02576-6
- Citations
- 1
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- Universitätsklinikum Essen